found glp-1 drugs changed the weight-loss and diabetes conversation, but Stanford researchers that about one in ten people may respond poorly because of genetics. That means the “miracle drug” story was always FDA Approves Wegovy Alternative for

The biological nature of these peptide-based medications makes them susceptible to degradation when exposed to temperatures outside recommended ranges

Patients diagnosed with T2DM have an increased risk of both cardiovascular and neurological diseases

Enebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, Lau DCW

Tirzepatide is a personalized GLP-1/GIP treatment, crafted for Willow patients who need a custom formulation tailored to their health goals

Our team of dedicated attorneys is committed to delivering personalized attention and top-notch legal services to ensure that your rights are protected and that you receive the compensation you deserve